T2C-M 10/500 Tablet ER contains a combination of Dapagliflozin 10mg and Metformin 500mg in extended-release tablet form. It belongs to the ANTI DIABETIC category and is manufactured and marketed by Ipca Laboratories Ltd.
Composition
- Dapagliflozin: 10mg
- Metformin: 500mg
Product Information
- Product Name: T2C-M 10/500 Tablet ER
- Generic: Dapagliflozin 10mg + Metformin 500mg
- Dosage Form: Extended-Release Tablet
- Manufacturer: Ipca Laboratories Ltd
- Marketer: Ipca Laboratories Ltd
- Category: ANTI DIABETIC
About Dapagliflozin and Metformin
Dapagliflozin is an SGLT2 inhibitor that helps lower blood glucose by reducing the reabsorption of glucose in the kidneys, allowing excess glucose to be eliminated through urine.
Metformin is an oral antidiabetic medicine that helps reduce blood glucose levels, primarily by decreasing glucose production in the liver and improving insulin sensitivity.
Usage Information
Use T2C-M 10/500 Tablet ER only as directed by your doctor or healthcare professional. Swallow the extended-release tablet as instructed and follow the prescribed dosage and schedule.
For complete product information, including dosage, storage instructions, precautions, contraindications, and expiry details, refer to the original packaging before use.
